CP
DFTX

CenterBook Partners’s Definium Therapeutics DFTX Stock Holding History

CenterBook Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Sell
41,255
-1,574
-4% -$38.9K 0.1% 238
2026
Q1 		$809K Sell
42,829
-95,986
-69% -$1.63M 0.04% 388
2025
Q4 		$1.86M Sell
138,815
-20,606
-13% -$255K 0.09% 273
2025
Q3 		$1.88M Buy
+159,421
New +$1.49M 0.09% 263

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

CenterBook Partners's DFTX Position: Q2 2026 in Review

CenterBook Partners reduced its Definium Therapeutics (DFTX) stake by 3.7% in Q2 2026, selling an estimated $38.9K and leaving 41,255 shares worth $1.94M. The position accounts for 0.1% of the portfolio, ranked #238.

CenterBook Partners first reported a position in DFTX in Q3 2025 and has held it in 4 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • CenterBook Partners held 41,255 shares of Definium Therapeutics worth $1.94M as of Q2 2026.
  • CenterBook Partners sold 1,574 Definium Therapeutics shares in Q2 2026, an estimated $38.9K.
  • Definium Therapeutics made up 0.1% of CenterBook Partners's portfolio in Q2 2026, its #238 holding.
  • CenterBook Partners first reported a position in Definium Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.